Informations sur le produit
Nom :
Lisinopril Dihydrate
Synonymes :
- [u'Lisinopril', u'Lisinopril Maleate (1:1)', u'Lisinopril Sulfate (1:2)', u'Lysinopril', u'MK-521', u'Prinivil', u'Zestril', u'83915-83-7', u'Renacor', u'UNII-E7199S1YWR', u'CHEBI:6503', u'E7199S1YWR', u'MK-521', u'Qbrelis', u'HSDB 6852', u'NCGC00017141-01', u'(S)-Lisinopril', u'CAS-83915-83-7', u'Zestril (TN)', u'(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate', u'(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate', u'1-(N(sup 2)-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate', u'DSSTox_CID_25600', u'DSSTox_RID_80993', u'DSSTox_GSID_45600', u'Ranolip', u'L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, dihydrate', u'N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate', u'(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate', u'L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-', u'L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-', u'MFCD01698825', u'lisinopril-zestril', u'lisinopril-dihydrat', u'C21H31N3O5.2H2O', u'Lisinopril [USAN:INN:BAN:JAN]', u'Prinivil (TN)', u'(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;dihydrate', u'Lisinopril (USP)', u'Prestwick_613', u'(S)-1-[N2-(1-Carboxy-3-phenylpropyl)-lysyl-proline dihydrate', u'Lisinopril [USAN:USP:INN:BAN:JAN]', u'AC1NSFPC', u'Lisinopril hydrate (JP17)', u'SCHEMBL542591', u'CHEMBL419213', u'DTXSID2045600', u'Lisinopril, >=98% (HPLC)', u'HMS1568N04', u'HMS2095N04', u'HMS3712N04', u'(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate', u'Tox21_110798', u'HY-18206A', u'AKOS015950799', u'Tox21_110798_1', u'AC-6226', u'AN-6585', u'API0005525', u'CCG-220301', u'CS-2444', u'KS-1078', u'NCGC00179623-04', u'H528', u'SC-25401', u'AB1004847', u'AX8136408', u'LS-118900', u'ST24047491', u'D00362', u'915L837', u'SR-01000801314', u'SR-01000801314-3', u'Lisinopril, United States Pharmacopeia (USP) Reference Standard', u'L-Proline,1-(N2(1-carboxy-3-phenylpropyl)-L-lysyl)-dihydrate,(S)', u'Lisinopril dihydrate, British Pharmacopoeia (BP) Reference Standard', u'Lisinopril dihydrate, European Pharmacopoeia (EP) Reference Standard', u'Lisinopril, Pharmaceutical Secondary Standard; Certified Reference Material', u'Lisinopril for peak identification, European Pharmacopoeia (EP) Reference Standard', u'Lisinopril for system suitability A, European Pharmacopoeia (EP) Reference Standard', u'(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate', u'lisinopril', u'Prinivil', u'Zestril', u'Prinzide', u'Lisinopril hydrate', u'Lysinopril', u'Zestoretic', u'Mixture Name', u'C21H31N3O5', u'Lisinopril [USAN:BAN:INN:JAN]', u'Deferasirox bis salicylamide impurity', u'CID5362118', u'CS-M-34867', u'CS-O-05581', u'C21-H31-N3-O5.2H2-O', u'2589H', u'B3290', u'1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline']
CAS :
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
441.5185
Formule :
C21H35N3O7
Degré de pureté :
98%
Couleur/Forme :
Solid
InChI :
InChI=1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1
Code InChI :
CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
